A Study of LY3090106 in Japanese and Caucasian Healthy Participants

NCT03736772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3090106
DRUG: Placebo

Sponsor

Eli Lilly and Company